MedTrace Logo

Retrospective Chart Review Screening Algorithm to Assess the Prevalence of PNH-clones

NCT05884060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 568

Last updated 2023-06-02

No results posted yet for this study

Summary

The present study is a non-interventional retrospective chart review study assessing the prevalence of PNH-clones in patients with PNH risk-factors aged ≥14 years and treated at our hospital. The objective of this study is to develop a PNH screening tool on the hospital Electronic Health Record (EHR) system. An algorithm defining PNH risk groups is developed.

Conditions

Interventions

OTHER

No intervention

No interventions

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • AZ Delta

    lead OTHER

Principal Investigators

  • Dries Deeren, MD · AZ Delta

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-20
Primary Completion
2022-03-01
Completion
2022-03-01
FDA Drug
Yes

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05884060 on ClinicalTrials.gov